VAI pilot studie in glioblastomen

Pilot study for the treatment response evaluation in glioblastoma patients with a new perfusion MRI technique; vessel architectural imaging

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21865

Enrollment

Registered

2018-02-21

Start date

2018-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma, Glioblastoom Brain tumour, hersentumor

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Histological confirmed glioblastoma after standard treatment - New contrast enhancing lesion on follow-up MRI - Written informed consent

Exclusion criteria

Exclusion criteria: - Minors (<18 years) - Residual enhancement on post-operative MRI - History of previous new enhancing lesion on follow-up MRI - Treatment different than standard treatment - Contraindication for MRI (ferromagnetic material in body, pregnancy, claustrophobia)

Design outcomes

Primary

Measure	Time frame
The primary outcome is to establish the practicability abd diagnostic accuracy of VAI-MRI for the treatment evaluation of glioblastoma.	—

Contacts

Public ContactBart Dijken, van

Department of radiology, Medical Imaging Center (MIC), University Medical Center Groningen (UMCG)

b.r.j.van.dijken@umcg.nl

Outcome results